AIM IMMUNOTECH INC. Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
AIM IMMUNOTECH INC. (AIM) had Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration of $51.35 million as of 2014-12-31, per its 10-K filed 2015-03-19.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration · last filed 2015-03-19
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $51.35M.
- 2013-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $45.58M.
- 2012-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $40.44M.
- 2011-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $36.61M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration |
|---|---|
| 2014-12-31 | $51.35M 10-K · filed 2015-03-19 |
| 2013-12-31 | $45.58M 10-K · filed 2015-03-19 |
| 2012-12-31 | $40.44M 10-K · filed 2014-03-14 |
| 2011-12-31 | $36.61M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |